Demi Siljeong (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Shireus Pharmaceutical Co., Ltd.
MFDS item code 201902259 · Approved 2019.04.12
This product's status changed to Expired on 2024.04.12. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of onychomycosis, cutaneous fungal infections (tinea pedis, tinea corporis, etc.), and tinea capitis
This medication is used to treat tinea pedis, tinea corporis, and tinea cruris caused by fungal infections of the skin in adults, and it is also used for onychomycosis. In children, it helps improve tinea capitis. Therefore, this medication is used for the treatment of fungal infections affecting the skin, nails, and scalp.
Administer terbinafine 125 mg twice daily or 250 mg once daily. The duration of treatment according to condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. In infections of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. Treatment of toenail infections usually requires 3 months, but in some patients it may take 6 months or longer. Treatment may take longer in patients with slow nail growth. In patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Use is not recommended in children under 2 years because there is no experience with administration. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be given regularly for the prescribed duration. Body weight under 20 kg (under 5 years): Administer 62.5 mg once daily. Because experience with use is limited, decide whether to administer after considering the benefits and risks of treatment. Body weight 20~40 kg (5 years to 12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Prior to administration, liver function tests and a history of liver disease must be confirmed. If any symptoms of liver dysfunction occur, use should be discontinued immediately and medical attention sought. Liver function tests should be conducted regularly during the treatment for the first 4-6 weeks, and if abnormalities are detected, medication should be stopped immediately. Since this medication can cause liver damage, caution is required for patients with impaired liver function. Not to be administered to patients with blood disorders, severe renal failure, children under 2 years of age, nursing mothers, and certain hereditary lactose intolerance patients. Patients with reduced kidney function, elderly individuals, and children with low body weight should use this medication cautiously, and it should be discontinued immediately if severe rash or allergic reactions occur. During the use of this medication, careful observation for symptoms such as skin rashes, nausea, fatigue, and jaundice is essential. Caution is needed if symptoms like dizziness occur while driving or operating machinery. This medication may interact with other drugs, so if there are any concomitant medications, notify your doctor or pharmacist. Especially when taken with drugs affecting liver metabolism, dosage adjustments may be necessary. Women who are pregnant or may become pregnant should consult their physician if this medication is necessary, and nursing mothers are advised to discontinue breastfeeding. In case of overdose, symptoms such as headaches, nausea, and dizziness may occur, and immediate medical attention should be sought. This medication should be kept out of the reach of children and stored in a tightly sealed container away from direct sunlight at room temperature.
Liver and biliary system failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, fatigue, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, skin hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriasis-like rash, exacerbation of psoriasis, alopecia, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangioedema, abdominal distension, decreased appetite, dyspepsia, mild abdominal pain, diarrhea, upper abdominal discomfort, thirst, vomiting, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory loss, decreased attention, insomnia, elevated BUN, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, fatigue, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory disability, vasculitis, permanent loss of smell, anosmia, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering. It should also be kept away from extremely hot or cold environments, and it is best stored at a normal room temperature between 1 to 30 degrees Celsius.
White to nearly colorless round tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Shireus Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.